Compensatory mutations restore fitness during the evolution of dihydrofolate reductase.

Whether a trade-off exists between robustness and evolvability is an important issue for protein evolution. Although traditional viewpoints have assumed that existing functions must be compromised by the evolution of novel activities, recent research has suggested that existing phenotypes can be robust to the evolution of novel protein functions. Enzymes that are targets of antibiotics that are competitive inhibitors must evolve decreased drug affinity while maintaining their function and sustaining growth. Utilizing a transgenic Saccharomyces cerevisiae model expressing the dihydrofolate reductase (DHFR) enzyme from the malarial parasite Plasmodium falciparum, we examine the robustness of growth rate to drug-resistance mutations. We assay the growth rate and resistance of all 48 combinations of 6 DHFR point mutations associated with increased drug resistance in field isolates of the parasite. We observe no consistent relationship between growth rate and resistance phenotypes among the DHFR alleles. The three evolutionary pathways that dominate DHFR evolution show that mutations with increased resistance can compensate for initial declines in growth rate from previously acquired mutations. In other words, resistance mutations that occur later in evolutionary trajectories can compensate for the fitness consequences of earlier mutations. Our results suggest that high levels of resistance may be selected for without necessarily jeopardizing overall fitness.

[1]  W. Sirawaraporn,et al.  Antifolate-resistant mutants of Plasmodium falciparum dihydrofolate reductase. , 1997, Proceedings of the National Academy of Sciences of the United States of America.

[2]  S. Krudsood,et al.  Independent Evolution of Pyrimethamine Resistance in Plasmodium falciparum Isolates in Melanesia , 2007, Antimicrobial Agents and Chemotherapy.

[3]  D. Hartl,et al.  Limits of adaptation: the evolution of selective neutrality. , 1985, Genetics.

[4]  D. Andersson.  The biological cost of mutational antibiotic resistance: any practical conclusions? , 2006, Current opinion in microbiology.

[5]  J. E. Hyde,et al.  Transcriptional analysis of genes encoding enzymes of the folate pathway in the human malaria parasite Plasmodium falciparum , 2002, Molecular microbiology.

[6]  David W Hall,et al.  Spontaneous Mutations in Diploid Saccharomyces cerevisiae , 2004, Genetics.

[7]  M. Schlitzer,et al.  Malaria Chemotherapeutics Part I: History of Antimalarial Drug Development, Currently Used Therapeutics, and Drugs in Clinical Development , 2007, ChemMedChem.

[8]  Dudley H. Williams,et al.  The evolutionary role of secondary metabolites--a review. , 1992, Gene.

[9]  B. Berkhout.  HIV-1 Evolution under Pressure of Protease Inhibitors: Climbing the Stairs of Viral Fitness , 1999, Journal of Biomedical Science.

[10]  J. Gillespie.  MOLECULAR EVOLUTION OVER THE MUTATIONAL LANDSCAPE , 1984, Evolution; international journal of organic evolution.

[11]  R. Summerbell,et al.  corrigendum: Fungus-growing ants use antibiotic-producing bacteria to control garden parasites , 2003, Nature.

[12]  Dan S. Tawfik,et al.  The 'evolvability' of promiscuous protein functions , 2005, Nature Genetics.

[13]  James A. Scott,et al.  Fungus-growing ants use antibiotic-producing bacteria to control garden parasites , 1999, Nature.

[14]  R. Sikorski,et al.  A system of shuttle vectors and yeast host strains designed for efficient manipulation of DNA in Saccharomyces cerevisiae. , 1989, Genetics.

[15]  F. Kondrashov.  In search of the limits of evolution , 2005, Nature Genetics.

[16]  H. A. Orr,et al.  THE POPULATION GENETICS OF ADAPTATION: THE ADAPTATION OF DNA SEQUENCES , 2002, Evolution; international journal of organic evolution.

[17]  Yongyuth Yuthavong,et al.  Insights into antifolate resistance from malarial DHFR-TS structures , 2003, Nature Structural Biology.

[18]  Thanat Chookajorn,et al.  Stepwise acquisition of pyrimethamine resistance in the malaria parasite , 2009, Proceedings of the National Academy of Sciences.

[19]  A. Cowman,et al.  Amino acids in the dihydrofolate reductase-thymidylate synthase gene of Plasmodium falciparum involved in cycloguanil resistance differ from those involved in pyrimethamine resistance. , 1990, Proceedings of the National Academy of Sciences of the United States of America.

[20]  C. Sibley,et al.  Novel Approaches to Tackling Malarial Drug Resistance Using Yeast , 2001, IUBMB Life - A Journal of the International Union of Biochemistry and Molecular Biology.

[21]  D. Andersson,et al.  Adaptation to the deleterious effects of antimicrobial drug resistance mutations by compensatory evolution. , 2004, Research in microbiology.

[22]  L. Hartwell,et al.  Analysis in yeast of antimalaria drugs that target the dihydrofolate reductase of Plasmodium falciparum. , 1997, Molecular and biochemical parasitology.

[23]  S. Chusacultanachai,et al.  Malarial (Plasmodium falciparum) dihydrofolate reductase-thymidylate synthase: structural basis for antifolate resistance and development of effective inhibitors , 2004, Parasitology.

[24]  D. Fidock,et al.  Advances in understanding the genetic basis of antimalarial drug resistance. , 2007, Current opinion in microbiology.

[25]  C. Sibley,et al.  Yeast as a model system to study drugs effective against apicomplexan proteins. , 1997, Methods.

[26]  S. Palumbi,et al.  Humans as the world's greatest evolutionary force. , 2001, Science.

[27]  M. DePristo,et al.  Mutational reversions during adaptive protein evolution. , 2007, Molecular biology and evolution.

[28]  Dan S. Tawfik,et al.  Enzyme promiscuity: evolutionary and mechanistic aspects. , 2006, Current opinion in chemical biology.

[29]  Lars Liljas,et al.  Compensatory adaptation to the deleterious effect of antibiotic resistance in Salmonella typhimurium , 2002, Molecular microbiology.

[30]  P. Newton,et al.  Adaptive Copy Number Evolution in Malaria Parasites , 2008, PLoS genetics.

[31]  J. Ghuysen,et al.  Nucleotide sequences of the pbpX genes encoding the penicillin‐binding proteins 2x from Streptococcus pneumoniae R6 and a cefotaxime‐resistant mutant, C506 , 1989, Molecular microbiology.

[32]  Gabriele Varani,et al.  Identification of the optimal third generation antifolate against P. falciparum and P. vivax. , 2005, Molecular and biochemical parasitology.

[33]  T. Kocagoz,et al.  Point mutations in Staphylococcus aureus PBP 2 gene affect penicillin-binding kinetics and are associated with resistance , 1995, Antimicrobial agents and chemotherapy.

[34]  Yongyuth Yuthavong,et al.  Novel antifolate resistant mutations of Plasmodium falciparum dihydrofolate reductase selected in Escherichia coli. , 2002, Molecular and biochemical parasitology.

[35]  D. Andersson,et al.  Virulence of antibiotic-resistant Salmonella typhimurium. , 1998, Proceedings of the National Academy of Sciences of the United States of America.

[36]  Nigel F. Delaney,et al.  Darwinian Evolution Can Follow Only Very Few Mutational Paths to Fitter Proteins , 2006, Science.

[37]  M. Gütlich,et al.  Disruption of the GTP-cyclohydrolase I gene in Saccharomyces cerevisiae. , 1996, Biochemical and biophysical research communications.